Intervention

Conventional Treatment

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting0

Common conditions14

Lead sponsors shown6

Clinical trials

6 shown

Huangqi Gegen Decoction for Endothelial Function in Type 2 Diabetes at Very High ASCVD RiskNCT07775664 · 2026-08-04

ACTIVE_NOT_RECRUITING

Clinical Efficacy of a telerehabilItation Protocol, for the Improvement of Balance in Degenerative Neurological DiseasesNCT07502066 · 2021-10-14

ACTIVE_NOT_RECRUITING

MSCs for Prevention of MI-induced HFNCT05043610 · 2021-09-15

Comparison Between the Effect of Ultrasound Debridement and Conventional Treatment in Diabetic Foot Ulcers (DFU).NCT04716790 · 2021-04-20

Intensive Lifestyle Intervention for Remission of Metabolic SyndromeNCT04116905 · 2020-10-01

Lee Silverman Voice Treatment Versus Standard Speech Therapy Versus Control in Hypophonia Rehabilitation in MSNCT04034277 · 2018-01-15

Common conditions

Multiple Sclerosis2 Cardiac Remodeling, Ventricular1 Cardiovascular Risk1 Diabetic Foot Ulcer1 Endothelial Dysfunction1 Heart Failure1 Metabolic Syndrome1 Myocardial Infarction First1 Myocardial Infarction, Acute1 Myocardial Infarction, Anterior Wall1 Parkinson Disease1 Regenerative Medicine1 STEMI1 Type 2 Diabetes Mellitus1

Leading sponsors

Fondazione Don Carlo Gnocchi ETS1 IRCCS San Camillo, Venezia, Italy1 Putuo Hospital, Shanghai University of Traditional Chinese Medicine1 Second Affiliated Hospital, Zhejiang University, School of Medicine1 Shiraz University of Medical Sciences1 Universidad Complutense de Madrid1

Trial status mix

ACTIVE_NOT_RECRUITING2

COMPLETED2

UNKNOWN2

Phase mix

NA5

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.